Mesothelioma Cancer, And The Asbetos Exposure Risk Component
Excessive cough, breathlessness, chest pain, weakness, cachexia (unexplained weight loss) etc are a fraction of the traits of a dreaded cancer called mesothelioma. It is a cancer affecting mesothelium of pleura, peritoneum, and/or pericardium. The cancer cells grow fast at times and lead to metastasis to distant organs in the body, thus evoking an undesirable prognosis.
If we examine the number of cases of this cancer worldwide, we percieve that it is regretably increasing over years and the information say that it may climb further. What is the root cause behind this damaging cancer?
The leading factor that governs the mesothelioma cancer is asbestos exposure. The contact with asbestos fiber is compared to setting ourselves up to be unsuccessful. The incidence of the disease is therefore high in occupations those get direct contact with asbestos. The sectors include ship yard field, roof shingles, construction trade, etc..
This is exactly why the laborers listed here are at the highest threat of getting the mesothelioma cancer. Also several solvents and chemicals used in specific industrial sectors are risky and could work as triggers for genetic mutation to happen.
Inevitably the genetic mutation continues as the key causative variable for almost any cancer. But asbestos exposure serves as a trigger for this mutation. The particles of asbestos are microscopic and they are often breathed in simply while working in its location. These particles when inhaled stick in the lungs and possess the capacity to remain there for very long period. This initiates the beginning of the cancer although it takes two or three decades for symptoms to surface.
That's the reason why many general practitioners overlook the diagnosis and consider the severe cough is because of pneumonia. Though very careful investigative studies, doctors can diagnose mesothelioma, and pleural biopsy is the final test that confirms the diagnosis. It is definitely good for the affected individual when this diagnosis is conducted at beginning stages so that his probability of recuperation and life improve by leaps and bounds.
Comprehending the dangerous effect of asbestos, for this reason, numerous governments today (like UK Government) have taken strict actions against the occupational environment and have resolved the amounts of asbestos allowable in the workplaces. But in countless developing countries, using asbestos is the norm, and this is increasing the incidence of mesothelioma.
The most significant aspect about avoidance of asbestos exposure is that for putting into action such prevention, employers need not devote huge dollars. Merely making accessible a well-fitting mask is enough for protecting enormous amounts of asbestos employees throughout the world. However this action seems difficult for some companies. That is the reason why these companies currently can be disciplined and sought compensations from by filing a lawsuit.
The mesothelioma sufferers can speak to mesothelioma law firm and file a case against such reckless employers. No question prevention is much better than a cure. But if your company cuased you to endure this serious cancer, you should be due compensation for health-related expenses and lost wages.
Just beware of this harmful cancer. If you or your family member is working in comparable industries, help to make certain your employer is taking care of appropriate preventive steps and if not, you can raise your voice in opposition to it! You ought to have safety at your job!
http://www.articlesbase.com/personal-injury-articles/mesothelioma-cancer-and-the-asbetos-exposure-risk-component-2155355.html
Mesothelioma Cancer, And The Asbetos Exposure Risk Component
Free Search
Translate
Friday, April 30, 2010
Monday, April 19, 2010
Mesothelioma Mesomark Blood Test
Mesothelioma Mesomark Blood Test
The Food and Drug Administration (FDA) approved the MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients. The MESOMARK test signifies the beginning of a new era in monitoring mesothelioma malignancies," said Dr. W. Jeffrey Allard, vice president and chief scientific officer of Fujirebio Diagnostics. "As the first in-vitro test for patients with this aggressive disease, it will enable doctors to more accurately detect recurrence and monitor treatment of patients."
The MESOMARK Assay test kit was developed to measure levels of a biomarker, mesothelin, in serum. Biomarkers are substances found in higher-than-normal concentrations in the blood, urine or body tissues of patients with certain types of cancers. The test may be used to monitor patients confirmed as having mesothelioma, for recurrence in patients following surgery, or for measuring response to therapies.
"Current diagnostic tests are less than ideal for quantification of changes in tumor volume, which is key to managing the disease," continued Allard. "As the MESOMARK results correlate with tumor volume*, it provides a much needed tool for monitoring patient status. It is our plan to collect additional data in the future to support the use of the test to detect mesothelioma."
MESOMARK test are now making it possible - with a simple blood test -to monitor response to treatment and to detect recurrence following treatment. This provides an important head start to patients racing against this aggressive cancer. "The Meso Foundation is the national research funding, patient support and advocacy organization dedicated to eradicating mesothelioma as a life-threatening disease.
Those wishing to take part in MESOMARK testing will be asked to provide one or more samples of blood. The blood samples will then be sent to a national reference laboratory for testing. In conjunction with other clinical and laboratory data obtained by your doctor, decisions regarding your treatment and care may be simplified. You may discontinue testing at any time.
http://www.articlesbase.com/cancer-articles/mesothelioma-mesomark-blood-test-814876.html
BGRYM73RN87S
Mesothelioma Mesomark Blood Test
The Food and Drug Administration (FDA) approved the MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients. The MESOMARK test signifies the beginning of a new era in monitoring mesothelioma malignancies," said Dr. W. Jeffrey Allard, vice president and chief scientific officer of Fujirebio Diagnostics. "As the first in-vitro test for patients with this aggressive disease, it will enable doctors to more accurately detect recurrence and monitor treatment of patients."
The MESOMARK Assay test kit was developed to measure levels of a biomarker, mesothelin, in serum. Biomarkers are substances found in higher-than-normal concentrations in the blood, urine or body tissues of patients with certain types of cancers. The test may be used to monitor patients confirmed as having mesothelioma, for recurrence in patients following surgery, or for measuring response to therapies.
"Current diagnostic tests are less than ideal for quantification of changes in tumor volume, which is key to managing the disease," continued Allard. "As the MESOMARK results correlate with tumor volume*, it provides a much needed tool for monitoring patient status. It is our plan to collect additional data in the future to support the use of the test to detect mesothelioma."
MESOMARK test are now making it possible - with a simple blood test -to monitor response to treatment and to detect recurrence following treatment. This provides an important head start to patients racing against this aggressive cancer. "The Meso Foundation is the national research funding, patient support and advocacy organization dedicated to eradicating mesothelioma as a life-threatening disease.
Those wishing to take part in MESOMARK testing will be asked to provide one or more samples of blood. The blood samples will then be sent to a national reference laboratory for testing. In conjunction with other clinical and laboratory data obtained by your doctor, decisions regarding your treatment and care may be simplified. You may discontinue testing at any time.
http://www.articlesbase.com/cancer-articles/mesothelioma-mesomark-blood-test-814876.html
BGRYM73RN87S
Mesothelioma Mesomark Blood Test
Subscribe to:
Posts (Atom)